Five Prime Therapeutics, Inc. to Present at Lazard Capital Markets 6th Annual Healthcare Conference
More News related to Press Releases
- U.S. Census Bureau Daily Feature for Nov. 23
- Report Finds Girls' Schools in Afghanistan Face Highest Risk of Violence; Suggests Steps for Preventing Attacks
- Majorities Reject Banning Defamation of Religion: 20 Nation Poll
- Peter Wilkinson Appointed IPREX President Asia Pacific
- Amid the Flu Epidemic, Don't Forget RSV in Young Children
SAN FRANCISCO--(BUSINESS WIRE)-- Five Prime Therapeutics, Inc., a clinical stage biologics company focused on discovery and development of innovative protein and antibody therapeutics, announced today that Julia P. Gregory, FivePrime's president and chief executive officer, will present at the Lazard Capital Markets 6th Annual Healthcare Conference at The St. Regis Hotel, in New York, New York on Wednesday, November 18, 2009 at 2:45 p.m. Eastern Time. Ms. Gregory will discuss FivePrime's advancing pipeline and business strategy.
About Five Prime Therapeutics, Inc.
Five Prime Therapeutics, Inc. is a clinical stage, privately-held company discovering and developing innovative protein and antibody therapeutics. Using its world-class biologics discovery platform, FivePrime is building a strong product pipeline in oncology, immunology and metabolic diseases. It has engineered a unique suite of technologies to comprehensively mine the entire extracellular human proteome- the complete collection of secreted proteins and receptors- to discover its therapeutic protein drugs and antibody targets. FivePrime is currently in Phase I with FP-1039 for solid tumors. Pharmaceutical partners include Johnson & Johnson's Centocor division and Pfizer, Inc. For more information, please visit www.fiveprime.com.
Source: Five Prime Therapeutics, Inc.
Stocks Mentioned
Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
